Dr. Gary Herbert Lyman, MD

  • Seattle, WA
  • Medical oncologist
NPI1770503054
Medicare services, 2016
20
Part D claims, 2016
16
Publications
131
Industry payments
$181,413
State license
1
Practice address
825 Eastlake Ave E, Seattle, WA 98109-4405
Practice phone
Call (206) 288-1000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Find Dr. Lyman's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Gary Herbert Lyman is a medical oncologist in Seattle, Washington

Dr. Lyman practices in Seattle, Washington.

Dr. Lyman's NPI, 1770503054, was assigned on July 20, 2006. Dr. Lyman holds Washington license MD60437383.

NPI and contact details
NPI enumeration date
July 20, 2006
NPI status
Active
Practice phone
(206) 288-1000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male

Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data

Dr. Gary Herbert Lyman's practice address is in Seattle, Washington

Dr. Lyman's practice address in the NPI Registry is 825 Eastlake Ave E, Seattle, WA 98109-4405. The practice phone is (206) 288-1000.

  • NPI Registry address
    825 Eastlake Ave E, Seattle, WA 98109-4405Phone(206) 288-1000

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dmand AI tracks the EHR system at Dr. Gary Herbert Lyman's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lyman practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Dr. Lyman's practiceAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Lyman practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Gary Herbert Lyman is one of 145 medical oncologists in Washington

Medical oncology is Dr. Lyman's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Lyman is licensed in Washington.

Specialties and state licenses

  • Medical oncology, WashingtonPrimaryLicense MD60437383 · taxonomy 207RX0202X

Medical oncologists near Dr. Lyman

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Gary Herbert Lyman billed Medicare for 20 services in 2016

CMS data shows 20 Medicare services from Dr. Lyman across 1 procedure code in 2016, all of them office visits. Medicare paid $677 for them. Every service was in an office.

Medicare services, 201620
Paid by Medicare$677
Procedure codes1

Dr. Lyman compared with the Washington median for medical oncologists, 2016

  • Dr. Lyman
  • Washington median
Medicare services
20vs 36294% below
Part D claims
16vs 18091% below

Medians across 131 medical oncologists in Washington with Dmand AI profiles that report each measure.

Dr. Lyman's most billed Medicare procedure codes, 2016

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Lyman

Need commercial claims for Dr. Lyman?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Lyman and other medical oncologists in Washington.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Gary Herbert Lyman's patients have a median age of 59

Across all payers, Dmand AI patient panel data puts Dr. Lyman's median patient age at 59, with 100% women.

Dr. Lyman's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 59

Patient panel by sex, all payers

  • Women100%
  • Men0%

Source: Dmand AI Patient Panel Data

Dr. Gary Herbert Lyman wrote 16 Medicare Part D claims in 2016

In 2016, Dr. Lyman wrote 16 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $1,127 in total drug cost.

Part D claims, 201616
Drugs named by CMS1
Total drug cost$1,127

Dr. Lyman's most prescribed drugs by claims, 2016

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

See all prescribing by Dr. Lyman

Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026

For MedTech and pharma teams

Find medical oncologists like Dr. Lyman by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Gary Herbert Lyman has 131 publications on record

Dmand AI links 131 papers to Dr. Lyman, published from 2016 to 2025. 2020 was the busiest year, with 26. The most frequent topics are COVID-19, SARS-CoV-2 and Biosimilar Pharmaceuticals. Dr. Lyman has published most often in Cancer Invest. Dr. Lyman's most frequent co-authors are Nicole M. Kuderer, MD, Petros Grivas, MD and David A. Garcia, MD.

Papers131
Years published2016 to 2025

Dr. Lyman's papers by year, 2016 to 2025

Topics Dr. Lyman writes about most

  • COVID-19
  • SARS-CoV-2
  • Biosimilar Pharmaceuticals
  • Breast Neoplasms
  • Venous Thromboembolism
  • Medical Oncology
  • Granulocyte Colony-Stimulating Factor
  • Pandemics

Dr. Lyman's most frequent co-authors

Recent publications by Dr. Lyman

See all 131 publications and co-authors

See who Dr. Lyman researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Lyman works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Gary Herbert Lyman received $181,413 in industry payments from 2016 to 2025

CMS Open Payments shows 136 general payments to Dr. Lyman from 21 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 74% of the total. Sandoz Inc. paid the most, $46,987. It also lists 15 research payments totaling $20,659 from 2017 to 2021.

General payments to Dr. Lyman by program year, 2016 to 2025

General payments to Dr. Lyman by kind, 2016 to 2025

$181.4Kin total
  • Consulting fees$134,54374%
  • Speaker and faculty fees$21,27212%
  • Travel and lodging$15,5239%
  • Honoraria$6,1503%
  • Food and beverage$3,9262%

Companies that paid Dr. Lyman the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Lyman

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Gary Herbert Lyman's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel Data
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Gary Herbert Lyman

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Gary Herbert Lyman's NPI number?

Dr. Gary Herbert Lyman's NPI number is 1770503054. It was assigned on July 20, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Gary Herbert Lyman?

Dr. Gary Herbert Lyman is a medical oncologist in Seattle, Washington. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Gary Herbert Lyman practice?

Dr. Lyman practices at 825 Eastlake Ave E, Seattle, WA 98109-4405.

What is Dr. Gary Herbert Lyman's office phone number?

The practice phone on file for Dr. Lyman is (206) 288-1000.

What is Dr. Gary Herbert Lyman's medical license number?

Dr. Lyman holds Washington license MD60437383.

Does Dr. Gary Herbert Lyman accept Medicare?

Yes. CMS data shows Dr. Lyman billed Medicare for 20 services in 2016.

What services does Dr. Gary Herbert Lyman bill to Medicare?

In 2016, Dr. Lyman's most billed Medicare services were office visit, established patient (99213).

What drugs does Dr. Gary Herbert Lyman prescribe most?

In 2016 Medicare Part D data, Dr. Lyman's most prescribed drugs by claims were Letrozole.

Has Dr. Gary Herbert Lyman received payments from drug or device companies?

CMS Open Payments shows $181,413 in general payments to Dr. Lyman from 21 companies from 2016 to 2025. The largest total came from Sandoz Inc.

How long has Dr. Gary Herbert Lyman been practicing?

Dr. Lyman's NPI was assigned in 2006.

Does Dr. Gary Herbert Lyman do research?

Dmand AI links 131 publications to Dr. Lyman, published from 2016 to 2025.

Who does Dr. Gary Herbert Lyman publish with?

Dr. Lyman's most frequent co-authors are Nicole M. Kuderer, MD (54 shared papers), Petros Grivas, MD (10 shared papers) and David A. Garcia, MD (9 shared papers).

Selling to medical oncology practices?

See medical oncologists in Washington by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)